FAQ

Topical Wound Spray HP802-247

Known as: Allogeneic Keratinocyte/Fibroblast Topical Spray HP802-247, HP802-247, HP802247 
A cell-based combination product consisting of a fibrinogen solution and a cell preparation containing allogeneic non-proliferating, living human… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2016
0120102016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Baseline factors affecting closure of venous leg ulcers.
OBJECTIVE The objective of this study was to characterize factors associated with closure of venous leg ulcers (VLUs) in a pooled… (More)
Is this relevant?
Review
2016
Review
2016
Phase 3 evaluation of HP802-247 in the treatment of chronic venous leg ulcers.
In 2012 we reported promising results from a phase 2 clinical trial of HP802-247, a novel spray-applied investigational treatment… (More)
Is this relevant?
2013
2013
Durability of healing from spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a 6-month follow-up.
Patients who participated in a Phase 2 trial of HP802-247 for venous leg ulcers were invited to participate in this 24-week… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2013
2013
Cell Persistence of Allogeneic Keratinocytes and Fibroblasts Applied in a Fibrin Matrix to Acute, Full Thickness Wounds.
HP802-247 is a living cell suspension of cultured allogeneic growth-arrested human male keratinocytes and fibroblasts (1:9 ratio… (More)
Is this relevant?
2013
2013
Allogeneic growth arrested keratinocytes and fibroblasts delivered in a fibrin spray accelerate healing in Mohs micrographic surgery wounds.
OBJECTIVES To determine the effectiveness of HP802-247 compared with bacitracin ointment in healing wounds resulting from Mohs… (More)
Is this relevant?
2012
2012
Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled…
BACKGROUND Many patients with venous leg ulcers do not heal with standard care. HP802-247 is a novel spray-applied cell therapy… (More)
Is this relevant?
2010
2010
Wound stimulation by growth-arrested human keratinocytes and fibroblasts: HP802-247, a new-generation allogeneic tissue engineering product.
BACKGROUND HP802-247 is a new-generation, allogeneic tissue engineering product consisting of growth-arrested, human… (More)
Is this relevant?